Oncology
HERTAB 250MG
Lapatinib 250 mg
HER2 kinase inhibitor for HER2-positive breast cancer.
- Composition
- Lapatinib
- Strength
- 250 mg
- Dosage form
- Tablet
- Pack size
- As per quotation
- Therapeutic area
- Oncology
- Documents
- COA, COPP & more on request
- Minimum order
- As per quotation
- Product code
- AG-1578
HERTAB 250MG contains Lapatinib 250 mg. HER2 kinase inhibitor for HER2-positive breast cancer. It is supplied as tablet. Anzora Global is a pharmaceutical exporter, importer and wholesaler based in Nagpur, India, supplying oncology products to licensed importers, distributors, hospitals and healthcare programmes worldwide. Certificates of analysis, COPP and other export documents can be provided on request. Contact us on WhatsApp or email for pricing, availability and minimum order quantity.